4//SEC Filing
Wilson Jason Douglas 4
Accession 0001209191-19-060929
CIK 0001358762other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:30 PM ET
Size
32.5 KB
Accession
0001209191-19-060929
Insider Transaction Report
Form 4
Wilson Jason Douglas
See Remarks
Transactions
- Conversion
Class A common stock
2019-12-16+10,000→ 17,350 total - Sale
Class A common stock
2019-12-16$206.88/sh−400$82,754→ 13,350 total - Sale
Class A common stock
2019-12-16$207.48/sh−400$82,992→ 12,950 total - Exercise/Conversion
Class B common stock
2019-12-16$11.00/sh+10,000$110,000→ 28,827 total→ Class A common stock (10,000 underlying) - Conversion
Class B common stock
2019-12-16−10,000→ 18,827 total→ Class A common stock (10,000 underlying) - Conversion
Class B common stock
2019-12-16−5,600→ 13,227 total→ Class A common stock (5,600 underlying) - Conversion
Class A common stock
2019-12-16+5,600→ 22,950 total - Sale
Class A common stock
2019-12-16$201.65/sh−1,300$262,146→ 21,150 total - Sale
Class A common stock
2019-12-16$202.51/sh−3,400$688,534→ 17,750 total - Sale
Class A common stock
2019-12-16$204.54/sh−1,480$302,722→ 13,950 total - Sale
Class A common stock
2019-12-16$205.07/sh−200$41,015→ 13,750 total - Sale
Class A common stock
2019-12-16$200.17/sh−500$100,086→ 22,450 total - Sale
Class A common stock
2019-12-16$203.60/sh−2,320$472,342→ 15,430 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-12-16−10,000→ 34,881 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (10,000 underlying)
Footnotes (11)
- [F1]The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $207.46 to $207.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F11]The options, representing a right to purchase a total of 101,881 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $200.01 to $200.575. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $201.18 to $202.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $202.005 to $202.95. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $203.01 to $204.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $204.20 to $204.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $205.05 to $205.10. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $206.88 to $206.89. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662395
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:30 PM ET
- Size
- 32.5 KB